BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37689824)

  • 1. Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank.
    Vlasschaert C; Akwo E; Robinson-Cohen C; Cook EK; Lanktree MB; Rauh MJ; Bick AG
    Leukemia; 2023 Nov; 37(11):2306-2308. PubMed ID: 37689824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of clonal hematopoiesis for hematologic neoplasms].
    Götze KS; Lengerke C
    Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank.
    Vlasschaert C; Heimlich JB; Rauh MJ; Natarajan P; Bick AG
    Circulation; 2023 Jan; 147(4):358-360. PubMed ID: 36689568
    [No Abstract]   [Full Text] [Related]  

  • 4. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
    Craven KE; Ewalt MD
    Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clonal hematopoiesis: causes and clinical implications].
    Burchert A
    Z Gerontol Geriatr; 2023 Feb; 56(1):65-72. PubMed ID: 36662242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clonal hematopoiesis: causes and clinical implications].
    Burchert A
    Inn Med (Heidelb); 2022 Oct; 63(10):1051-1058. PubMed ID: 35969263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke.
    Mayerhofer E; Strecker C; Becker H; Georgakis MK; Uddin MM; Hoffmann MM; Nadarajah N; Meggendorfer M; Haferlach T; Rosand J; Natarajan P; Anderson CD; Harloff A; Hoermann G
    Stroke; 2023 Apr; 54(4):938-946. PubMed ID: 36789775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis of indeterminate potential: Overmedicalization or context dependant relevance?
    Patnaik MM
    Leuk Res; 2023 Oct; 133():107356. PubMed ID: 37523988
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
    Marshall CH; Gondek LP; Luo J; Antonarakis ES
    Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of lymphoid and myeloid clonal hematopoiesis.
    Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
    Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic.
    Bolton KL; Zehir A; Ptashkin RN; Patel M; Gupta D; Sidlow R; Papaemmanuil E; Berger MF; Levine RL
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):357-367. PubMed ID: 32089215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal Hematopoiesis and Its Impact on Human Health.
    Ahmad H; Jahn N; Jaiswal S
    Annu Rev Med; 2023 Jan; 74():249-260. PubMed ID: 36450282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into clonal hematopoiesis and its relation to cancer risk.
    Mitchell SR; Gopakumar J; Jaiswal S
    Curr Opin Genet Dev; 2021 Feb; 66():63-69. PubMed ID: 33422951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.
    Reed SC; Croessmann S; Park BH
    Clin Cancer Res; 2023 Apr; 29(8):1403-1411. PubMed ID: 36454121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations.
    Loh PR; Genovese G; Handsaker RE; Finucane HK; Reshef YA; Palamara PF; Birmann BM; Talkowski ME; Bakhoum SF; McCarroll SA; Price AL
    Nature; 2018 Jul; 559(7714):350-355. PubMed ID: 29995854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
    Osman A; Patel JL
    Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers.
    Feusier JE; Arunachalam S; Tashi T; Baker MJ; VanSant-Webb C; Ferdig A; Welm BE; Rodriguez-Flores JL; Ours C; Jorde LB; Prchal JT; Mason CC
    Blood Cancer Discov; 2021 May; 2(3):226-237. PubMed ID: 34027416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.